Evidence map›Paper›PMID 26279470›Full record

ArticleScientific reports2015

Photodynamic activation as a molecular switch to promote osteoblast cell differentiation via AP-1 activation.

Toshihiro Kushibiki, Yupeng Tu, Adnan O Abu-Yousif, Tayyaba Hasan

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Anti-Skin Aging Potential of Methoxyflavones fromFoods (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Toshihiro Kushibiki1] Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, USA, 40 Blossom Street, Boston, MA 02114, USA [2] Department of Medical Engineering, National Defense Medical College, Japan, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan.
Yupeng TuWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, USA, 40 Blossom Street, Boston, MA 02114, USA.
Adnan O Abu-YousifWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, USA, 40 Blossom Street, Boston, MA 02114, USA.
Tayyaba HasanWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, USA, 40 Blossom Street, Boston, MA 02114, USA.

Funding

Small Molecule Enhancers of Photodynamic Therapy for Skin CancerP01CA084203 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Bryan Quilty Spring · 2001 to 2026
$27.9M
Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetryR01CA160998 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HASAN, TAYYABA · 2011 to 2015
$2.0M
NCI NIH HHS P01 CA084203NCI NIH HHS R01 CA160998
6 · The paper itself

Abstract

In photodynamic therapy (PDT), cells are impregnated with a photosensitizing agent that is activated by light irradiation, thereby photochemically generating reactive oxygen species (ROS). The amounts of ROS produced depends on the PDT dose and the nature of the photosensitizer. Although high levels of ROS are cytotoxic, at physiological levels they play a key role as second messengers in cellular signaling pathways, pluripotency, and differentiation of stem cells. To investigate further the use of photochemically triggered manipulation of such pathways, we exposed mouse osteoblast precursor cells and rat primary mesenchymal stromal cells to low-dose PDT. Our results demonstrate that low-dose PDT can promote osteoblast differentiation via the activation of activator protein-1 (AP-1). Although PDT has been used primarily as an anti-cancer therapy, the use of light as a photochemical "molecular switch" to promote differentiation should expand the utility of this method in basic research and clinical applications.

Indexed as

Aminolevulinic AcidAnimalsCell DifferentiationCells, CulturedCell SurvivalLasersMesenchymal Stem CellsMiceMitochondriaModels, MolecularOsteoblastsPhotosensitizing AgentsRatsReactive Oxygen SpeciesTranscription Factor AP-1Aminolevulinic AcidPhotosensitizing AgentsReactive Oxygen SpeciesTranscription Factor AP-1

Identifiers

PMID26279470
PMCPMC4538568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.